Latest Clinical Papers

Hepatobiliary-phase (HBP) gadolinium ethoxybenzyl-diethylenetriaminepentaacetic acid MRI (Gd-EOB-DTPA) for pretreatment prediction of efficacy-to-standard-therapies based on Barcelona Clinic Liver Cancer algorithm: an up-todate review

The HBP in EOB-MRI reflecting molecular and pathological factors, may predict hepatocellular carcinoma (HCC) treatment efficacy and guide treatment choices.

A multivariate model based on gadoxetic acidenhanced MRI using Li-RADS v2018 and other imaging features for preoperative prediction of dualphenotype hepatocellular carcinoma (DPHCC)

Gd-EOB-DTPA MRI effectively differentiates between DPHCC and non-DPHCC.

Magnetic resonance imaging-based risk factors of hepatocellular carcinoma after direct-acting antiviral therapy: multicenter observational study

Gd-EOB-DTPA MRI could predict the development of hypervascular HCC following HCV DAA therapy.